JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3826
CALL
AES
AES
$10.7B
| $1.65M | ﹤0.01% |
92,000
| – | – |
2023 Q4
1 quarter
|
|
3827
Avantis Real Estate ETF
AVRE
$837M
| $1.65M | ﹤0.01% |
38,995
-156
| -0.4% | -$6.51K |
2023 Q4
1 quarter
|
|
3828
iShares High Yield Systematic Bond ETF
HYDB
$1.58B
| $1.64M | ﹤0.01% |
35,205
-24,899
| -41% | -$1.15M |
2023 Q3
2 quarters
|
|
3829
iShares International Equity Factor ETF
INTF
$3.67B
| $1.64M | ﹤0.01% |
54,968
+7,918
| +17% | +$226K |
2022 Q4
5 quarters
|
|
|
APLS
3830
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $1.64M | ﹤0.01% |
27,900
+25,100
| +896% | +$1.6M |
2023 Q3
2 quarters
|
|
3831
CALL
Ultragenyx Pharmaceutical
RARE
$1.47B
| $1.63M | ﹤0.01% |
+35,000
| New | +$1.65M |
2024 Q1
0 quarters
|
|
|
3832
PUT
Ultragenyx Pharmaceutical
RARE
$1.47B
| $1.63M | ﹤0.01% |
+35,000
| New | +$1.65M |
2024 Q1
0 quarters
|
|
3833
Taboola.com
TBLA
$889M
| $1.63M | ﹤0.01% |
367,725
+152,824
| +71% | +$681K |
2021 Q3
10 quarters
|
|
|
LAZR
3834
DELISTED
Luminar Technologies
LAZR
| $1.63M | ﹤0.01% |
55,251
-3,673
| -6% | -$134K |
2021 Q1
12 quarters
|
|
3835
Pennant Group
PNTG
$1.38B
| $1.63M | ﹤0.01% |
83,129
+16,280
| +24% | +$274K |
2019 Q4
17 quarters
|
|
3836
Cipher Digital
CIFR
$6.04B
| $1.63M | ﹤0.01% |
316,801
+30,513
| +11% | +$106K |
2021 Q3
10 quarters
|
|
3837
BRC Group Holdings
RILY
$201M
| $1.63M | ﹤0.01% |
76,865
-147,139
| -66% | -$2.95M |
2017 Q4
25 quarters
|
|
3838
Marcus & Millichap
MMI
$1.07B
| $1.63M | ﹤0.01% |
47,613
+8,431
| +22% | +$309K |
2017 Q4
25 quarters
|
|
3839
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.95B
| $1.63M | ﹤0.01% |
29,703
+1,863
| +7% | +$101K |
2020 Q4
13 quarters
|
|
3840
CALL
Fair Isaac
FICO
$14.7B
| $1.62M | ﹤0.01% |
+1,300
| New | +$1.63M |
2024 Q1
0 quarters
|
|
3841
Amerant Bancorp
AMTB
$1.12B
| $1.62M | ﹤0.01% |
69,729
+14,084
| +25% | +$318K |
2019 Q1
20 quarters
|
|
|
UGIC
3842
DELISTED
UGI Corporation
UGIC
| $1.62M | ﹤0.01% |
27,856
-1,437
| -5% | -$82.6K |
2022 Q2
7 quarters
|
|
3843
United States Copper Index Fund
CPER
$744M
| $1.62M | ﹤0.01% |
64,441
+23,609
| +58% | +$568K |
2021 Q2
11 quarters
|
|
3844
CALL
Dutch Bros
BROS
$5.27B
| $1.62M | ﹤0.01% |
+49,000
| New | +$1.45M |
2024 Q1
0 quarters
|
|
|
APGE
3845
DELISTED
Apogee Therapeutics
APGE
| $1.62M | ﹤0.01% |
24,333
+1,269
| +6% | +$55.4K |
2023 Q3
2 quarters
|
|
3846
PUT
Upstart Holdings
UPST
$2.34B
| $1.61M | ﹤0.01% |
+60,000
| New | +$1.77M |
2024 Q1
0 quarters
|
|
3847
National Vision
EYE
$1.33B
| $1.61M | ﹤0.01% |
72,615
-54,627
| -43% | -$1.15M |
2017 Q4
25 quarters
|
|
3848
Standard BioTools
LAB
$266M
| $1.61M | ﹤0.01% |
592,646
+448,270
| +310% | +$1.08M |
2016 Q4
29 quarters
|
|
3849
Invesco Total Return Bond ETF
GTO
$2.43B
| $1.6M | ﹤0.01% |
34,207
+21,765
| +175% | +$1.02M |
2023 Q3
2 quarters
|
|
3850
CALL
Dominion Energy
D
$54.1B
| $1.59M | ﹤0.01% |
+32,400
| New | +$1.51M |
2024 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.